Patrick W. Serruys

3.7k total papers · 204.9k total citations
2.2k papers, 114.5k citations indexed

About

Patrick W. Serruys is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Patrick W. Serruys has authored 2.2k papers receiving a total of 114.5k indexed citations (citations by other indexed papers that have themselves been cited), including 1.8k papers in Surgery, 1.3k papers in Cardiology and Cardiovascular Medicine and 1.1k papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Patrick W. Serruys's work include Coronary Interventions and Diagnostics (1.7k papers), Cardiac Imaging and Diagnostics (1.0k papers) and Cardiac Valve Diseases and Treatments (532 papers). Patrick W. Serruys is often cited by papers focused on Coronary Interventions and Diagnostics (1.7k papers), Cardiac Imaging and Diagnostics (1.0k papers) and Cardiac Valve Diseases and Treatments (532 papers). Patrick W. Serruys collaborates with scholars based in Netherlands, United Kingdom and United States. Patrick W. Serruys's co-authors include Pim J. de Feyter, Yoshinobu Onuma, Stephan Windecker, Evelyn Regar, A. Pieter Kappetein, Ron T. van Domburg, Antonio Colombo, Eugène McFadden, Héctor M. García‐García and Marcel van den Brand and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Patrick W. Serruys

2.1k papers receiving 110.3k citations

Hit Papers

Clinical End Points in Co... 1985 2026 1998 2012 2007 2002 2009 2011 2007 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical End Points in Coronary Stent Trials
    2007 4.2k citations Donald E. Cutlip, Stephan Windecker et al. Circulation profile →
  2. A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
    2002 3.0k citations Marie‐Claude Morice, Patrick W. Serruys et al. New England Journal of Medicine profile →
  3. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
    2009 2.6k citations Patrick W. Serruys, Marie‐Claude Morice et al. New England Journal of Medicine profile →
  4. A Prospective Natural-History Study of Coronary Atherosclerosis
    2011 2.1k citations Gregg W. Stone, Akiko Maehara et al. New England Journal of Medicine profile →
  5. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
    2007 1.3k citations Joost Daemen, Peter Wenaweser et al. The Lancet profile →
  6. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
    2013 1.1k citations Friedrich W. Mohr, Marie-Claude Morice et al. The Lancet profile →
  7. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
    2004 1.0k citations Eugène McFadden, Evelyn Regar et al. The Lancet profile →
  8. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
    2011 895 citations Nicolò Piazza, Eugenia Nikolsky et al. European Heart Journal profile →
  9. High-Resolution Spiral Computed Tomography Coronary Angiography in Patients Referred for Diagnostic Conventional Coronary Angiography
    2005 800 citations Nico R. Mollet, Filippo Cademartiri et al. Circulation profile →
  10. Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease
    2001 773 citations Patrick W. Serruys, Felix Unger et al. New England Journal of Medicine profile →
  11. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.
    1988 722 citations Patrick W. Serruys, Kevin J. Beatt et al. Circulation profile →
  12. Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries
    1996 662 citations Willem J. van der Giessen, Heleen M.M. van Beusekom et al. Circulation profile →
  13. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis
    2009 616 citations Francesco Prati, Evelyn Regar et al. European Heart Journal profile →
  14. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.
    1985 615 citations Johan H. C. Reiber, Patrick W. Serruys et al. Circulation profile →
  15. Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries
    2001 602 citations J. Eduardo Sousa, Marco A. Costa et al. Circulation profile →
  16. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
    2009 583 citations Patrick W. Serruys, John A. Ormiston et al. The Lancet profile →
  17. Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
    2002 563 citations Patrick W. Serruys JAMA profile →
  18. Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials
    2011 540 citations Martin B. Leon, Nicolò Piazza et al. Journal of the American College of Cardiology profile →
  19. Coronary-Artery Stents
    2006 536 citations Patrick W. Serruys, Michael J.B. Kutryk et al. New England Journal of Medicine profile →
  20. Late Angiographic Stent Thrombosis (LAST) Events With Drug-Eluting Stents
    2005 528 citations Andrew T.L. Ong, Eugène McFadden et al. Journal of the American College of Cardiology profile →
  21. Angiographic Follow-up after Placement of a Self-Expanding Coronary-Artery Stent
    1991 522 citations Patrick W. Serruys, Bradley H. Strauss et al. New England Journal of Medicine profile →
  22. Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents
    2001 512 citations Marco A. Costa, Alexandre Abizaid et al. Circulation profile →
  23. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
    2018 502 citations Héctor M. García‐García, Eugène McFadden et al. Circulation profile →
  24. Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
    2013 499 citations Vasim Farooq, David van Klaveren et al. The Lancet profile →
  25. A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents
    2007 499 citations Christian Spaulding, Joost Daemen et al. New England Journal of Medicine profile →
  26. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
    2008 496 citations John A. Ormiston, Patrick W. Serruys et al. The Lancet profile →
  27. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approval
    2008 475 citations Nicolò Piazza, Eberhard Grube et al. EuroIntervention profile →
  28. Comprehensive Assessment of Coronary Artery Stenoses
    2008 455 citations Carlos A.G. van Mieghem, Francesca Pugliese et al. Journal of the American College of Cardiology profile →
  29. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
    2008 453 citations Stephan Windecker, Patrick W. Serruys et al. The Lancet profile →
  30. Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis
    2011 413 citations Patrick W. Serruys, Yoshinobu Onuma et al. Journal of the American College of Cardiology profile →
  31. Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival
    1986 406 citations Maarten L. Simoons, Patrick W. Serruys et al. Journal of the American College of Cardiology profile →
  32. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
    2014 393 citations Patrick W. Serruys, Bernard Chevalier et al. The Lancet profile →
  33. Clinical Outcomes After Transcatheter Aortic Valve Replacement Using Valve Academic Research Consortium Definitions
    2012 390 citations Philippe Généreux, Stuart J. Head et al. Journal of the American College of Cardiology profile →
  34. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial
    2016 349 citations Patrick W. Serruys, Bernard Chevalier et al. The Lancet profile →
  35. Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial
    2014 285 citations Marie-Claude Morice, Patrick W. Serruys et al. Circulation profile →
  36. PCI and CABG for Treating Stable Coronary Artery Disease
    2019 278 citations Torsten Doenst, Patrick W. Serruys et al. Journal of the American College of Cardiology profile →
  37. Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention
    2020 195 citations Ajay J. Kirtane, Björn Redfors et al. Journal of the American College of Cardiology profile →
  38. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis
    2021 132 citations Patrick W. Serruys, A. Pieter Kappetein et al. The Lancet profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Patrick W. Serruys 85.4k 71.9k 46.2k 27.2k 8.9k 2.2k 114.5k
David R. Holmes 42.0k 0.5× 63.7k 0.9× 25.4k 0.5× 14.0k 0.5× 5.2k 0.6× 1.4k 89.1k
Martin B. Leon 41.7k 0.5× 48.4k 0.7× 24.1k 0.5× 20.4k 0.8× 2.8k 0.3× 1.2k 72.8k
Renu Virmani 42.2k 0.5× 36.1k 0.5× 19.8k 0.4× 23.4k 0.9× 6.3k 0.7× 981 79.9k
Gregg W. Stone 56.7k 0.7× 63.3k 0.9× 31.4k 0.7× 15.8k 0.6× 4.2k 0.5× 1.6k 87.7k
Valentı́n Fuster 34.0k 0.4× 53.8k 0.7× 22.9k 0.5× 21.3k 0.8× 5.0k 0.6× 1.3k 101.1k
Eric J. Topol 41.9k 0.5× 63.0k 0.9× 23.7k 0.5× 9.3k 0.3× 6.2k 0.7× 1.3k 113.3k
Roxana Mehran 42.4k 0.5× 53.0k 0.7× 22.7k 0.5× 14.3k 0.5× 2.4k 0.3× 1.3k 75.8k
Jeroen J. Bax 21.5k 0.3× 60.0k 0.8× 26.8k 0.6× 9.2k 0.3× 5.6k 0.6× 1.6k 74.9k
Antonio Colombo 39.7k 0.5× 38.8k 0.5× 20.4k 0.4× 13.9k 0.5× 2.2k 0.2× 1.3k 55.4k
Robert O. Bonow 21.4k 0.3× 64.7k 0.9× 20.3k 0.4× 12.3k 0.5× 3.3k 0.4× 619 80.4k

Countries citing papers authored by Patrick W. Serruys

Since Specialization
Citations

This map shows the geographic impact of Patrick W. Serruys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick W. Serruys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick W. Serruys more than expected).

Fields of papers citing papers by Patrick W. Serruys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick W. Serruys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick W. Serruys. The network helps show where Patrick W. Serruys may publish in the future.

Co-authorship network of co-authors of Patrick W. Serruys

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick W. Serruys. A scholar is included among the top collaborators of Patrick W. Serruys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick W. Serruys. Patrick W. Serruys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yen Wei Breakdown of academic impact, for papers by Ben L. Feringa Breakdown of academic impact, for papers by Shaobin Wang Breakdown of academic impact, for papers by Kazuo Shinozaki Breakdown of academic impact, for papers by Younan Xia Breakdown of academic impact, for papers by John A. Spertus Breakdown of academic impact, for papers by Tien Yin Wong Breakdown of academic impact, for papers by Michael R. Hamblin
Rankless by CCL
2026